Solmap Pharmaceuticals Inc is categorized under Research and Development Laboratories in Chelmsford, MA and active since 2008.
Solmap Pharmaceuticals Inc was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact David Lancia Jr at the company’s single location by writing to 199 Riverneck Road, Chelmsford, Massachusetts MA 01824 or by phoning (303) 865-8420. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Solmap Pharmaceuticals Inc |
| Contact Person: | David Lancia Jr |
| Address: | 199 Riverneck Road, Chelmsford, Massachusetts 01824 |
| Phone Number: | (303) 865-8420 |
| Website Address: | formatherapeutics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Solmap Pharmaceuticals Inc was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact David Lancia Jr for inquiries that concern Solmap Pharmaceuticals Inc by calling the company number (303) 865-8420, as your correspondence is most welcome. Additionally, the physical location of the single location of Solmap Pharmaceuticals Inc can be found at the coordinates as well as the street address 199 Riverneck Road in Chelmsford, Massachusetts 01824.
For its online presence, you may visit Solmap Pharmaceuticals Inc’s website at formatherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.